NCT00099710

Data

{
  "briefSummary": "The purpose of this study is to examine the safety and tolerability of curcumin, and to determine its effect on patients with mild to moderate Alzheimer's Disease (AD).",
  "completionDate": "2007-12",
  "conditions": [
    "Alzheimer's Disease"
  ],
  "enrollmentCount": 33,
  "enrollmentType": "ESTIMATED",
  "nctId": "NCT00099710",
  "phase": "PHASE2",
  "sponsorId": "john-douglas-french-foundation",
  "startDate": "2003-07",
  "status": "COMPLETED",
  "studyType": "INTERVENTIONAL",
  "title": "A Phase II, Double-Blind, Placebo-Controlled Study of the Safety and Tolerability of Two Doses of Curcumin C3 Complex Versus Placebo in Patients With Mild to Moderate Alzheimer's Disease",
  "url": "https://clinicaltrials.gov/study/NCT00099710"
}

History in this collection

1. addedv1.0.0Jun 12, 2026this version